NCT03895697View on ClinicalTrials.gov

A Trial to Compare the Efficacy and Safety of 2 Different Batches of Subcutaneous Dasiglucagon in Patients With T1DM

PHASE3CompletedINTERVENTIONAL
Enrollment

92

Participants

Timeline

Start Date

March 26, 2019

Primary Completion Date

July 30, 2019

Study Completion Date

July 30, 2019

Conditions
HypoglycemiaDiabetes Mellitus, Type 1
Interventions
DRUG

dasiglucagon

Glucagon analogue

Trial Locations (1)

M4G 3E8

LMC Diabetes & Manna Research, Toronto

Sponsors

Lead Sponsor

Zealand Pharma
All Listed Sponsors
lead

Zealand Pharma

INDUSTRY